NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.
Ewa Poleszak, Piotr Wlaź, Andrzej Wróbel, Sylwia Fidecka, Gabriel Nowak
文献索引:Pharmacol. Rep. 60(5) , 655-63, (2008)
全文:HTML全文
摘要
The anxiolytic-like activity of magnesium in mice during the elevated plus maze (EPM) has been demonstrated previously. In the present study, we examined the involvement of NMDA/glutamate receptor ligands on the magnesium effect on the EPM. We demonstrated that low, ineffective doses of NMDA antagonists (the competitive NMDA antagonist CGP 37849, 0.3 mg/kg; an antagonist of the glycineB sites, L-701,324, 1 mg/kg; a partial agonist of the glycineB sites, D-cycloserine, 2.5 mg/kg; and the non-competitive NMDA antagonist MK-801, 0.05 mg/kg) administered together with an ineffective dose of magnesium (10 mg/kg) evoked a significant increase in the percentage of time spent in the open arm of the maze (an index of anxiety). Moreover, magnesium-induced anxiolytic-like activity (20 mg/kg) was antagonized by D-serine (100 nmol/mouse), an agonist of glycineB site of the NMDA receptor complex. The present study demonstrates the involvement of the NMDA/glutamate pathway in the magnesium anxiolytic-like activity in the EPM in mice, and that this activity particularly involves the glycineB sites.
相关化合物
相关文献:
2003-05-01
[Kidney Int. 63(5) , 1764-75, (2003)]
2005-02-15
[Physiol. Behav. 84(2) , 251-64, (2005)]
2004-01-01
[Pol. J. Pharmacol. 56(1) , 59-66, (2004)]
1990-01-01
[Prog. Clin. Biol. Res. 361 , 421-7, (1990)]
2008-06-02
[Neuroscience 153(4) , 1370-9, (2008)]